The Market Reports

Synopsis
The global market for Vascular Interventional Surgery Robot was estimated to be worth US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 281 million by 2031 with a CAGR of 20.7% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Vascular Interventional Surgery Robot cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
A Vascular Interventional Surgery Robot (VISR) is a computer-assisted robotic system designed to perform minimally invasive endovascular procedures with enhanced precision, stability, and safety. These robots assist surgeons in navigating catheters, guidewires, and stents through blood vessels to treat conditions like arterial blockages, aneurysms, or stroke.
In the global market, the core manufacturers of vascular interventional surgery robot include Corindus Vascular Robotics (Siemens) etc, and the top 1 manufacturer accounts for about 70% of the market share. The market include Europe, North America and Asia Pacific, with a share of 54%, 33% and 9%. image navigation accounted for 86% and magnetic navigation accounted for 14%. the product is mainly used in cardiovascular and cerebrovascular fields, with a share of 30% and 27%.
Market Drivers
Rising Prevalence of Cardiovascular Diseases: Cardiovascular conditions contribute to nearly 18 million deaths annually. Vascular interventional surgery robots can improve procedural accuracy by 50% and reduce complications, meeting the strong demand for innovative treatment solutions.
Technological Advancements: The integration of artificial intelligence (AI) and machine learning (ML), real - time imaging systems, and haptic feedback mechanisms is enhancing the capabilities of robotic systems. For example, around 40% of the vascular interventional robots introduced in recent years feature AI - driven functionalities, which can improve surgical outcomes and reduce error rates by about 25%.
Market Challenges
High Cost: The high costs of acquisition, installation, and maintenance of vascular interventional surgery robots can hinder their widespread adoption, especially in developing regions with limited healthcare budgets.
Technical Complexity: These robots require a high level of technical expertise for operation and maintenance. Surgeons and medical staff need to undergo specialized training to use them effectively, which may limit their use in some hospitals with insufficient technical resources.
Regulatory Hurdles: The medical device industry is highly regulated, and vascular interventional surgery robots are no exception. Obtaining regulatory approvals can be a time - consuming and costly process, which may slow down the market entry of new products.
This report aims to provide a comprehensive presentation of the global market for Vascular Interventional Surgery Robot, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vascular Interventional Surgery Robot by region & country, by Type, and by Application.
The Vascular Interventional Surgery Robot market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Interventional Surgery Robot.
Market Segmentation
By Company
Robocath
J&J
Stereotaxis
Siemens
WeMed Medical
Segment by Type
Image Navigation
Magnetic Navigation
Segment by Application
Cardiovascular
Cerebrovascular
Peripheral Blood Vessels
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vascular Interventional Surgery Robot manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Vascular Interventional Surgery Robot in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Vascular Interventional Surgery Robot in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index